HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 51.03.02.db01-1278v1 51/3/557    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ritz-Laser, B. Articles by Philippe, J. Search for Related Content PubMed PubMed Citation Articles by Ritz-Laser, B. Articles by Philippe, J. Social Bookmarking                What's this?

Molecular Detection of Circulating ß-Cells After Islet Transplantation

¹ Diabetes Unit, Department of Internal Medecine, University Hospital Geneva, Geneva, Switzerland
² Clinic of Digestive and Transplant Surgery, Department of Surgery, University Hospital Geneva, Geneva, Switzerland

Islet transplantation is a promising treatment for type 1 diabetes. However, islet grafts are submitted to multiple injuries, including immunosuppressive drug toxicity, hyperglycemia, hypoxia, unspecific inflammatory reactions, as well as allo- and autoimmune destruction. Therapeutic approaches to these damage mechanisms require early detection of islet injury, which is currently not feasible because of the lack of efficient markers. Based on the hypothesis of islet dissociation and release of islet cells into the circulation during islet injury, we designed a highly sensitive and specific molecular assay, able to detect two ß-cells per milliliter of venous blood by RT-PCR of insulin mRNA. We report that circulating ß-cells can be demonstrated up to 10 weeks after intraportal islet transplantation, as assessed after six islet grafts in four type 1 diabetic patients. Furthermore, our results suggest that the time during which circulating islet cells can be detected may depend on the graft environment and the immunosuppressive regimen. This test may allow better estimation of islet cell loss and identification of factors involved in islet graft injury.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. R. MacGregor, S. J. Williams, P. Y. Tong, K. Kover, W. V. Moore, and L. Stehno-Bittel Small rat islets are superior to large islets in in vitro function and in transplantation outcomes Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E771 - E779. [Abstract] [Full Text] [PDF]

				C. Wang, Z. Ling, and D. Pipeleers Comparison of cellular and medium insulin and GABA content as markers for living {beta}-cells Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E307 - E313. [Abstract] [Full Text] [PDF]